Psychoactive substances and pregnancy. Study of a hospital population in Uruguay;Sustancias psicoactivas y embarazo. Estudio en una población hospitalaria de Uruguay

Trastornos Adictivos

Volumn 10, Issue 2, 2008, Pages 98-103

  Magri, R ^a,f   Miguez, H A ^b   Hutson, J ^c   Suarez H ^d   Menendez A ^e   Parodi, V ^a   Koren, G ^c   Bustos, R ^a  

^a Centro Hospitalario Pereira Rossell   (Uruguay)

^b CONICET ^*  (Argentina)

^c UNIVERSITY OF TORONTO   (Canada)

^d Junta Nacional de Drogas   (Uruguay)

^e Comisión de Control de Tabaquismo ^*  (Uruguay)

^f NONE   (Uruguay)

Author keywords

Alcohol; Biomarkers; Illicit drugs; Pregnancy; Tobacco

Indexed keywords

AMPHETAMINE; BIOLOGICAL MARKER; CANNABIS; FATTY ACID ESTER; ILLICIT DRUG; PSYCHOTROPIC AGENT;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; COCAINE DEPENDENCE; DRUG ABUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH SURVEY; HOSPITAL ADMISSION; HUMAN; LEGAL ASPECT; MAJOR CLINICAL STUDY; MECONIUM; PHYSICIAN; PREGNANCY; PUBLIC HOSPITAL; RISK ASSESSMENT; SMOKING; URUGUAY;

EID: 47649128344     PISSN: 15750973     EISSN: 15782638     Source Type: Journal    
DOI: 10.1016/S1575-0973(08)74551-3     Document Type: Article

References (41)

1. AAP- American Academy of Paediatrics Committee on Substance Abuse and Committee on Children with Disabilities. Fetal Alcohol Syndrome and Alcohol-Related Neurodevelopment Disorders. Pediatrics. 2000;106:358-61.
2. Lemoine P, Harouseau H. A propos de 127 cas. Les enfants des parents alcooliques: Anomalies observées. Ouest Med. 1968;21:476-82.
3. Sokol RJ. Alcohol and abnormal outcomes of pregnancy. Can Med Assoc. 1981;125:143-8.
4. Jouitteau B, Massias C, Sanyas P. Foetal alcohol syndrome. J Radiol. 2000;81:1709-12.
5. Jones KL, Smith DW. Recognition of the fetal alcohol syndrome in early infancy. Lancet. 1973;2:999-1001.
6. Mann A. Smoking exposure in uterus increases risk of later addiction. NIDA Notes. 2004;19(4):4. Consultado el 18/06/2007. Disponible en: http://www.nida.nih.gov/NIDA_notes/NNvol19N4/Smoking.html
7. Huestis MA, Choo RE. Drug abuse's smallest victims. In utero drug exposure. Forensic Science International. 2002;128:20-30.
8. Kullander S, Kallen B. A prospective study of smoking and pregnancy. Acta Obstet Gynecol Scand. 1971;50:83-94.
9. Cnattingius S, Signorello LB, AnnerénG, Clausson B, Ekbom A, Ljunger E, et al. Caffeine intake and the risk of first-trimester spontaneous abortion. N Engl J Med. 2000;343:1839-45.
10. Lacassie H, Núñez G. Drogas y embarazo. Revisión bibliográfica. Revista Chilena de Anestesia. 2000;29:2. Consultado el 18/06/2007. Disponible en: http://www.socanestesia.cl/rev_anestesia/0010/drogas. asp
11. Espinoza R. Efectos de algunas drogas sobre el feto y el recién nacido. En: Pérez A, Donoso E, editores. Obstetricia. 3.a ed. Santiago: Publicaciones Técnicas Mediterráneo; 1999. p. 989-1007.
12. Guerri C. Neuroanatomical and neurophysiological mechanisms involved in central nervous system dysfunctions induced by prenatal alcohol exposure. Alcoholism Clin Exp Res. 1998;22:303-12.
13. Xu Y, Xiao R, Li Y. Effect of ethanol on the development of visceral yolk sac. Hum Reprod. 2005;20:2509-16.
14. Kay HH, Tsoi S, Grindle K, Magness RR. Markers of oxidative stress in placental villi exposed to ethanol. J Soc Gynecol Investig. 2006;13:118-21.
15. Lee RD, An SM, Kim SS, Rhee GS, Kwack SJ, Seok JH, et al. Neurotoxic effects of alcohol and acetaldehyde during embryonic development. J Toxicol Environ Health. 2005;68:2147-62.
16. Hartl MW, Shibley IA. Supraphysiological acetaldehyde levels suppress growth in chicken embryos. Alcohol. 2002;28:111-5.
17. Meschke LL, Holl JA, Messelt S. Assessing the risk of fetal alcohol syndrome: understanding substance use among pregnant women. Neurotoxicol Teratol. 2003;25:763-5.
18. Little J, Cardy A, Munger RG. Tobacco smoking and oral clefts: a meta-analysis Bull World Health Org. 2004;82:213-8.
19. Jaakkola JJ, Gissler M. Maternal smoking in pregnancy, fetal development, and childhood asthma. Am J Public Health. 2004;94(1):136-40.
20. Cnattingius S, Signorello LB, Annerén G, Clausson B, Ekbom A, Ljunger E, et al. Caffeine intake and the risk of first-trimester spontaneous abortion. N Engl J Med. 2000;343:1839-45.
21. Matijasevich A, BarrosFC, Forteza CA, Díaz-Rossello JL. Atención de la salud en niños de muy bajo peso al nacer en Montevideo, Uruguay: comparación entre los sectores público y privado. Journal de Pediatría. 2001;77:313-20.
22. Devane CL, SIimkins JW, Miller RL, Braun SB. Tissue distribution of cocaine in the pregnant rat. Life Sci. 1989;45:1271-76.
23. Dow-Edwards DL, Freed LA, Fico TA. Structural and functional effects of prenatal cocaine exposure in adult rat brain. Dev Brain Res. 1990;57:263-8.
24. Mena M, Navarrete O, Corvalán S, Bedregal P. Drogadicción embriofetal por abuso de pasta base de cocaína durante el embarazo. Rev Med Chile. 2000;128:1093-100.
25. Chasnoff IJ, Burns WJ, Schnoll SH, Burns KA. Cocaine use in pregnancy. N Engl J Med. 1985;313:666-9.
26. Zuckerman B, Frank DA, Hingson R, Amaro H, Levenson SM, Kayne H, et al. Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med. 1989;320:762-8.
27. Cornelius M, Goldschmidt L, Day N, Larkby C. Alcohol, tobacco and marijuana use amongst pregnant teenagers: a six year follow-up of offspring growth effects. Neurotoxicol Teratol. 2002;24:703-10.
28. Lester BM, Dreher M. Effects of marijuana use during pregnancy on newborn cry. Child Dev.1989;60:765-71.
29. Todd R, Triunfo P. Bajo peso al nacer en el Uruguay. Implicancias de Trabajo Facultad de Ciencias Sociales. Documento de trabajo; 2006.
30. CLAP http://www.clap.ops-oms.org/web_2005/NOVEDAD/LIBRO%20SIP.pdf
31. Stoler JM, Huntington KS, Peterson CM, Peterson KP, Daniel P, Aboagye KK, et al. The prenatal detection of significant alcohol exposure with maternal blood markers. J Pediatr. 1998;133:346-52.
32. Derauf C, Katz A, Easa D. Agreement between maternal self-reported ethanol intake and tobacco use during pregnancy and meconium assays for fatty acid etil esteres and cotinine. Am J Epidemiol. 2003;158(7):705-9.
33. Bearer CF, Lee S, Salvator AE, Minnes S, Swick A, Yamashita T, et al. Etil linoleate in meconium: a biomarker for prenatal ethanol exposure. Alcohol Clin Exp Res. 1999;23:487-93.
34. Bearer CF, Jacobson JL, Jacobson SW, Barr D, Croxford J, Molteno CD, et al. Validation of a new biomarker of fetal exposure to alcohol. J Pediat. 2003;143:463-9.
35. Moore C, Jones J, Lewis D, Buchi K. Prevalence of fatty acid ethyl esters in meconium specimens. Clin Chem. 2003;49:133-6.
36. Ostrea EM Jr, Hernández JD, Bielawski DM, Kan JM, Leonardo GM, Abela MB, et al. Fatty acid ethyl esters in meconium: are they biomarkers of fetal alcohol exposure and effect? Alcohol Clin Exp Res. 2006;30:1152-9.
37. Chan D, Bar-Oz B, Pellerin B, Paciorek C, Klein J, Kapur B, et al. Population baseline of meconium fatty acid ethyl esters among infants of nondrinking women in Jerusalem and Toronto. Ther Drug Monit. 2003;25:271-8.
38. Derauf C, Katz AR, Frank DA, Grandinetti A, Easa D. The prevalence of methamphetamine and other drug use during pregnancy in Hawaii. J Drug Issues. 2003;33:1001-16.
39. Fuchs F, Fuchs AR, Poblete VF, Risk A. Effect of alcohol on threatened premature labor. Am J Obstet Gynecol. 1967;99:627-37.
40. The UN Administrative Committee on Nutrition Low Birth Weight. Report of a Meeting. Dhaka, Bangladesh: The UN Administrative Committee on Nutrition Low Birth Weight; 1999.
41. Bortman M. Factores de riesgo de bajo peso al nacer. Rev Panam Salud Pública. 1998;3:180-4.